Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemia

Blood. 2016 May 12;127(19):2356-8. doi: 10.1182/blood-2016-02-697193. Epub 2016 Mar 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine / analogs & derivatives
  • Agammaglobulinaemia Tyrosine Kinase
  • Aged
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Leukemia, Lymphocytic, Chronic, B-Cell / enzymology
  • Male
  • Middle Aged
  • Nervous System / drug effects*
  • Nervous System Diseases / drug therapy*
  • Nervous System Diseases / enzymology
  • Nervous System Diseases / etiology*
  • Piperidines
  • Protein Kinase Inhibitors / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrazoles / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Retrospective Studies

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • Adenine